Current Activities

Current Activities

The consortium started to enroll patients since this year. 3 clinical trials were approved by the consortium and have started. We have provided the information of the consortium and called for clinical trials to famous International pharmaceutical factory. The information of clinical trials now started including the follows:   

  1. Improved AKI using “adsorbent” Clinical prospective multicenter randomized controlled trial (RCT) study (102-4129A3).
  2. The Effect of Endotoxin Adsorbed Hemoperfusion on the Microcirculation in Patients with Severe Sepsis and Septic Shock.
  3. Validation the device from Advanced Circuits Research Laboratory
  4. The winner of 2014 Recipient of the Outstanding Research Award for Excellent Contribution in Medical Research from National Taiwan University Hospital.

Current activities

 
編號
計畫名稱
參與機構單位
國內目標收案數
目前收案數
1
Nationwide epidemiology of acute kidney injury and predictability of renal biomarkers
NTUH、CMUH、 TCVGH、 CGMH 、MMH、CTH、KMUCMH、BTCGH
500
 
2
Nationwide epidemiology and prognosis of acute kidney injury
NTUH、CMUH、 TCVGH、 CGMH 、MMH、CTH、KMUCMH、BTCGH
8,000
 
3
An oral uremic toxin absorbent (AST-120) to treat patients with acute kidney injury – a multicenter double blinded randomized controlled study
NTUH、CMUH、 TCVGH、 CGMH 、MMH、CTH、KMUCMH、BTCGH
210
 
4
A randomized, double-blind, placebo-controlled, multi-center study to assess the safety and efficacy of different oral doses of BAY 94-8862 in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic nephropathy
NTUH、TVGH、TMUH、KCGMH
14
22
5
A Phase III, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients not on Dialysis
TCVGH、KMUH、KCGMH、CMUH、CCH、TSGH、NCKUH、TMUH、Chi Mei Medical Center、NTUH、KVGH、KTGH
96
10
6
The effect of Endotoxin Adsorber Hemoperfusion on the Microcirculation in Patients with Severe Sepsis and Septic Shock
NTUH、TMUH、BTCGH
40
10
7
TRK-100STP PhaseIIb/III clinical study protocol-Chronic renal failure (Primary Glomerular Disease/Nephrosclerosis)
CGMH,Linkou、KMUCMH、FEMH、Shin Kong Wu Ho-Su Memorial Hospital、TVGH、KCGMH、MMH、CMUH、CCH、TVGH、Chi Mei Medical Center、KVGH、Show Chwan Health Care System、E-DA hospital、LCGMH、KTGH、MTUH-Yun-Lin Branch
108
6
8
A randomized,controlled, open-label, multi-centre, parallel-group study to assess all-cause mortality and cardiovascular morbidity in patients with chronic kidney disease on dialysis and those not on renal replacement therapy under treatment with
MIRCERA® or reference ESAs.
NTUH、KMUCMH
40
43

圖片